3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
6
Gastrointestinal
6
Thoracic
5
Dermatologic
2
Breast
2
Sarcoma
1
Gynecologic
1
Genitourinary
1
Conditions
Sarcoma
317
Glioblastoma
176
Gliosarcoma
166
Astrocytoma
125
Brain Neoplasms
117
Osteosarcoma
101
Glioma
97
Central Nervous System Neoplasms
96
Oligodendroglioma
92
Neuroblastoma
88
Neoplasms
87
Melanoma
87
Breast Neoplasms
81
Ovarian Neoplasms
70
Lymphoma
67
Dendritic Cell Sarcoma, Interdigitating
64
Sarcoma, Ewing
63
Rhabdomyosarcoma
63
Recurrence
63
Carcinoma, Non-Small-Cell Lung
63
Precursor Cell Lymphoblastic Leukemia-Lymphoma
59
Burkitt Lymphoma
59
Lymphoma, Non-Hodgkin
55
Medulloblastoma
53
Colorectal Neoplasms
53
Wilms Tumor
52
Pancreatic Neoplasms
51
Neoplasm Metastasis
49
Lymphoma, Large B-Cell, Diffuse
47
Carcinoma, Hepatocellular
44
Interventions
pembrolizumab
1
Cetuximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Noonan Syndrome
×
Sarcoma
×
Clear all
NCT04670679
2026-03-25
FLAGSHP-1
Erasca, Inc.
Phase 1
Active not recruiting
90 enrolled